Loading organizations...
Loading organizations...
Biopharmaceutical company developing macrophage cell therapy.
Resolution Therapeutics has raised $13.1M across 1 funding round.
Resolution Therapeutics has raised $13.1M in total across 1 funding round.
Resolution Therapeutics has raised $13.1M in total across 1 funding round.
Resolution Therapeutics's investors include Edward Hodgkin.
Resolution Therapeutics has raised $13.1M across 1 funding round. Most recently, it raised $13.1M Series A Extension in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 5, 2022 | $13.1M Series A Extension | Edward Hodgkin |